1. The following procedures are to be used for the collection of samples to be analysed IAW AS/NZS 4308:2001 'Recommended Practice for the Collection, Detection and Quantitation of Drugs of Abuse in urine' (the Standard). Any departure from the specified sample collection procedures will not invalidate a drug test provided that the procedures followed do not cast doubt on the accuracy and reliability of the collection process with due regard to sample security and chain of custody requirements.
2. On arrival at the testing area, the collector shall establish the identity of the person providing the specimen (donor). Acceptable means of identification will be an ASIC or drivers licence or other suitable identification. If identification cannot be established unequivocally, the collector will not proceed with the collection.
3. The collector shall confirm that the donor is aware of their Company policy, with regard to collection and testing procedures, if they are not, explain these to them.
4. The donor will be required to wash hands, following which the donor will remain in the presence of the collector and will be denied further access to water, soap, or any other materials including toilet cleanser.
5. The donor will provide a sample into a designated collection container in a partitioned section that allows for individual privacy. The donor will hand this sample to the collector.
6. Upon receiving the sample, the collector shall determine that there is sufficient sample to enable all required testing to be performed, and request additional sample if required.
7. Within four (4) minutes of the sample being taken, the collector will check the validity of the sample by ensuring that the temperature of the sample is between 33°-38°C (90°-100°F). The temperature will be measured using a device separate or part of the collection container.
8. After the sample has been provided, the collector will conduct an initial test. The donor may then wash his/her hands.
9. If the validity of the sample cannot be established, or if it is suspected that the sample may have been adulterated or substituted, another sample shall be collected as soon as possible using the above procedures. Both samples will be forwarded to an accredited laboratory for testing in accordance with the analysis requirements set out in the Standard.
10. Both the collector and the donor shall keep the sample in view at all times prior to it being sealed and labeled.
11. If the initial test is positive the sample shall be transferred from the collection container into two bottles in approximately equal proportions and marked "Sample A' and 'Sample B'.
12. The collector shall request that the donor witness the transfer of the sample into the bottles, the placement of tamper-proof seals or equivalent devices over both bottle caps and down the sides of the bottles as well as the placement of the bottles into a container which will be sealed in front of the donor.
13. Prior to the samples being sealed in a container, the donor shall initial the ID seals on each bottle to certify that it is the sample collected from them. The ID seals will also list two (2) unique identifiers and the date of collection.
14. All the ID contained on the identification seals will be entered onto the Drug Test Form and will be signed by both the donor and the collector certifying ownership of the sample as well as giving consent for the sample to be tested in accordance with their Company DAMP and the Standard. The employee will be given a copy of the form at the end of the proceedings for their records.
15. The samples collected will be forwarded to an accredited laboratory for testing in accordance with the procedures recommended in the Standard.